Nomura Holdings’s Takeda Pharmaceutical TAK Stock Holding History

Nomura Holdings’s Portfolio TAK Stock Details TAK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-451,500	Closed	-$6.44M	–	2009
2023 Q4	$6.44M	Buy	+451,500	New	+$6.41M	0.02%	582
2023 Q2	–	Sell	-443,850	Closed	-$7.31M	–	1627
2023 Q1	$7.31M	Buy	+443,850	New	+$7.07M	0.02%	447
2022 Q4	–	Sell	-431,550	Closed	-$5.6M	–	1701
2022 Q3	$5.6M	Buy	+431,550	New	+$6M	0.02%	514
2021 Q1	–	Sell	-111,250	Closed	-$2.02M	–	2262
2020 Q4	$2.02M	Hold	111,250	–	–	﹤0.01%	843
2020 Q3	$1.99M	Hold	111,250	–	–	﹤0.01%	666
2020 Q2	$2M	Hold	111,250	–	–	0.01%	564
2020 Q1	$1.69M	Sell	111,250 -60,000	-35%	-$1.09M	0.01%	495
2019 Q4	$3.39M	Hold	171,250	–	–	0.01%	522
2019 Q3	$2.97M	Hold	171,250	–	–	0.01%	571
2019 Q2	$3.03M	Buy	171,250 +50,000	+41%	+$910K	0.01%	599
2019 Q1	$2.49M	Buy	+121,250	New	+$2.44M	0.01%	611

Other funds holding TAK

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

BIP

Brandes Investment Partners La Jolla, California $14.1B AUM 25.52% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return

Nomura Holdings's TAK Position: Q2 2025 in Review

Nomura Holdings sold out of Takeda Pharmaceutical (TAK) in Q2 2025, closing a stake of 22,700 shares — an estimated $338K sold.

Nomura Holdings first reported a position in TAK in Q1 2019 and held it in 14 quarters. The position peaked at $8.25M in Q1 2019. 316 funds tracked by Wall St. Rank hold TAK as of Q2 2025.

Nomura Holdings reported no remaining Takeda Pharmaceutical position as of Q2 2025 after selling out during the quarter.
Nomura Holdings sold 22,700 Takeda Pharmaceutical shares in Q2 2025, an estimated $338K.
Nomura Holdings first reported a position in Takeda Pharmaceutical in Q1 2019 and held it in 14 quarters.
Nomura Holdings's Takeda Pharmaceutical position peaked at $8.25M in Q1 2019.
316 funds tracked by Wall St. Rank held Takeda Pharmaceutical as of Q2 2025.

Based on Nomura Holdings's 13F filing for Q2 2025, filed 14 Aug 2025.